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Abstract: We recently reported a novel neuro-immuno co-operation between vasoactive 
intestinal peptide (VIP) and fraktalkine (FKN) in recruiting human mast cells to the asthmatic 
airway that provided a classical example of priming effect on mast cells migratory function, but 
the role of the F-actin in human mast cell chemotaxis’ priming is poorly deﬁ  ned. Therefore the 
aim of this study was to further investigate the biophysical role of the cytoskeletal element; the 
F-actin, intracellular reorganization and its polymerization in mast cell priming of chemotaxis 
function. In the present communication it is shown by immunoﬂ  uoresence confocal microscopy 
analysis that physical F-actin intracellular reorganization in a membrane bound manner on 
human mast cell is involved in VIP-induced priming of human mast cell chemotaxis against 
FKN. The F-actin reorganization was calcium independent and without modiﬁ  cation of its 
contents as assessed by ﬂ  uorescence-activated cell scanning analysis. These results identify a 
novel role for the biophysical association of F-actin in the crosstalk between neuro-inﬂ  ammatory 
mediators and mast cells and may be an important target for therapeutic modalities in allergic 
inﬂ  ammation.
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Introduction
Human airway smooth muscle cells (HASMC) play a signiﬁ  cant role in recruiting 
mast cells to the asthmatic bronchi (Brightling et al 2005; Sutcliffe et al 2006). The 
contribution of fraktalkine (FKN), the CX3C chemokine produced by HASMC to 
mast cell chemotaxis, needed the cooperation of the neuropeptide vasoactive intestinal 
peptide (VIP), without altering FcεR1 or CD117 expression on mast cells (El-Shazly 
et al 2006). Similar synergistic cooperation between stem cell factor and tumor 
necrosis factor-α on intercellular adhesion molecule-1 expression on human mast 
cells was demonstrated, which further provide insight for cross-talk between different 
signaling pathways that can help in recruiting mast cells to the allergic inﬂ  ammatory 
site (Tsang et al 2005).
Chemotaxis primer is an agent that will not induce chemotaxis when it reacts 
with its speciﬁ  c receptor on the cell surface, but will put the cell in the ready-to-go 
position to re-stimulation and will do so even with a suboptimal dose of the proper 
chemokine that attracts the cell type. This scenario of crosstalk between mediators 
and inﬂ  ammatory cells is applicable to the pathophysiology of allergic rhinitis and 
asthma where there is a pool of allergic mediators at different concentrations involved 
in the allergic site.
The literature review is rich in the different signal transduction pathways and 
the different protein kinases involved in mast cell chemotaxis. However, apart from International Journal of General Medicine 2008:1 28
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its well acknowledged cytoskeletal shape changes, little is 
known about the role played by the F-actin in the signal 
transduction of mast cell chemotaxis (Jackson et al 2005; 
Samayawardhena et al 2006; Rivera et al 2007; Kim et al 
2007; Samayawardhena et al 2007).
Accordingly, the current study was designed to look 
into the role of F-actin in the signal transduction of priming 
mast cell chemotaxis function. Our recently reported novel 
clinical crosstalk model of the neuro-immuno-inﬂ  amatory 
axis in recruiting mast cells to the airway; FKN-VIP-mast 




Human mast cell line (HMC-1) (Butterﬁ  eld et al 1988) was 
cultured in 10% fetal calf serum/Dubecco’s modiﬁ  ed Eagle’s 
Medium and was passaged every 3–5 days with trypsin- 
ethylenediaminetetraacetic acid (EDTA) (Invitrogen Life 
Technologies, Carlsbad, CA).
Chemotaxis assay
Chemotactic experiments were performed in 48-well micro-
chemotaxis chambers as described elsewhere (Berger et al 
2001). As for chemotaxis assay of primed HMC-1, cells were 
ﬁ  rst incubated with 1 μM VIP for 30 minutes (Sigma-Aldrich, 
St. Louis, MO), washed twice and resuspended in the culture 
media before inducing their chemotaxis response against 
10 ng/ml FKN (R and D Systems, Minneapolis, MN). Mast 
cells were then counted by microscopy in 5 selected high 
power ﬁ  elds (magniﬁ  cation   400). Results of the chemo-
taxis experiments were expressed as mast cells/5 high power 
ﬁ  elds (5hpf).
Microspectroﬂ  uorimetry
Changes in HMC-1 intracellular calcium concentration were 
assessed using the Ca2+-sensitive probe indo-1 (calbiochem) 
precisely as previously described (Bonnet et al 2003). 10 μM 
ATP was used as positive control that demonstrated the 
ability of HMC-1 to mobilize intracellular calcium. 1 μM 
VIP, 10 ng/ml FKN, and 1 μM VIP + 10 ng/ml FKN ability to 
mobilize intracellular calcium were tested in similar fashion.
Actin reorganization assessment 
with phalloidin-FITC
As for actin reorganization and content assessment, after 
each challenge, HMC-1 were fixed in cold methanol 
for 20 minutes and permeabilized with 0.1% saponin 
(Sigma-Aldrich) for another 30 minutes. The cells were then 
stained with phalloidin-ﬂ  uorescein isothiocyanate (FITC) 
(Sigma-Aldrich) labeled for 1 hour in the dark, on ice, and 
analyzed by ﬂ  uorescence-activated cell scanning (FACS) or 
confocal microscopy.
Results and discussion
In the past decade or so, intensive research in the ﬁ  elds of 
neuropeptides and immune cells has resulted in accumulating 
evidence that supports the existence of neuroimmune axis 
(Numa et al 1992; El-Shazly et al 1996, 1997). The 28 amino 
acid VIP polypeptide, which exists in the parasympathetic 
nerves, and to a lesser extent in the sensory ﬁ  bers, is one of 
the most abundant of the neuropeptides found in the upper 
and lower airways (Ghatei et al 1982; Baranuik et al 1990). 
It has been detected in the ﬂ  uids of hypersensitivity reactions 
(Mosimann et al 1993). The biological effects of VIP on 
airway functions include regulation of vascular tone, airway 
caliber, and mucus secretion (Said 1982; Peatﬁ  eld et al 1983; 
Palmer et al 1986; Stjarne et al 1991).
On inﬂ  ammatory cells, VIP has the potential to modulate 
T-lymphocyte and human eosinophil chemotaxis (Delgado 
et al 1995; El-Shazly et al 2000) at wide range of doses. How-
ever, VIP at the same wide range doses did not induce human 
mast cell chemotaxis, but acted as a primer to suboptimal dose 
of 10 ng/ml FKN-induced mast cell chemotaxis (El-Shazly 
et al 2006). Nonetheless, little is known about the role of 
F-actin in mast cell priming of chemotaxis function.
FKN the CX3C chemokine attracts human mast cells 
in boyden chambers in a classical bell-like shape dose-
dependent manner with optimal doses of 25–50 ng/ml 
through a CX3CR1 receptor stimulation that is linked to 
PKC epsilon and delta, increase in F-actin contents and rapid 
shape changes (El-Shazly et al 2006). Herein, it is shown that 
the low nonstimulatory dose of 10 ng/ml caused mast cell 
chemotaxis after the cells have been primed by 1 μM VIP 
that, per se, did not cause chemotaxis (Figure 1a).
Chemokine-mediated signal transduction is believed to 
involve (i) Ca2+ mobilization, protein kinase C and hetero-
trimeric GTP-binding proteins in a classical view (Downey 
1994), and (ii) kinases and phosphatases, adaptor proteins, 
and small GTP-binding proteins in an alternate view (Bokoch 
1995; Bacon et al 1996; Kanal et al 1997). Thus, the role of 
Ca2+ as a second messenger was investigated. Neither FKN 
nor VIP mobilized intracellular Ca2+ in mast cells. Similar 
results were obtained after the cells have been primed with 
VIP (Figure 1b) indicating that the VIP-priming effect was 
Ca2+-independent.International Journal of General Medicine 2008:1 29
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Figure 1 (a) Priming effect of 1 μM VIP on 10 ng/ml FKN-induced mast cells chemotaxis. Upper panel (i, A1–D1) demonstrate the data of the number of mast cells 
per 5 selected high power ﬁ  eld (5 hpf; × 400) ± SEM of 6 independent experiments each performed in triplicate. Asterisks indicate p   0.05 by paired t-test. Lower panel 
(ii,   A2–D2) demonstrates mast cells in 1 selected HPF as one experiment representative of 6 all showing similar results. (b) Effect of 1μM ATP, 1μM VIP, 10 ng/ml FKN, and 
1 μM VIP + 10 ng/ml FKN on mast cells intracellular calcium mobilization. Results are of one representative of 4 independent experiments all showing similar results. Traces 
are from 27–125 cells. (c) Fluocytometry of F-actin in mast cells. Y-axis represent cell count while X-axis represent the mean ﬂ  uorescent, where 1 = Control, 2 = Buffer, 3 = VIP 
(1 μM), 4 = FKN (10 ng/ml), 5 = VIP (1 μM) + FKN (10 ng/ml). Histograms are one representative of 6 different experiments all showing similar results. (d) F-actin dynamics 
and cell shape changes induced by different stimulants. (A) Control-15 minutes stimulation (Buffer), (B) VIP 1 μM-15 minutes stimulation, (c) VIP 1 μM-30 minutes stimulation, 
(D) FKN 10 ng/ml-15 minutes stimulation (E) VIP 1μM-15 minutes stimulation, cells were washed twice, and re-stimulated with FKN 10ng/ml for 5 minutes. Images are from 

















ATP 10 micro Mol.
 FKN 10 ng  /  ml VIP 1 micro Mol.
30 sec













































































MInternational Journal of General Medicine 2008:1 30
El-Shazly
The suboptimal dose of 10 ng/ml FKN did not cause 
signiﬁ  cant increase of F-actin contents or shape changes, 
but reorganized the intracellular F-actin homogeneously 
in a clump-like manner within the spherical cell (compare 
FACS results 1 and 2 with 4 in Figure 1c and confocal images 
A with D in Figure 1d). However, the same suboptimal 
dose caused a rapid increase in the F-actin contents and 
shape changes after the cells were primed by a physiological 
dose of VIP (compare FACS results 1 and 2 with 5 in 
Figure 1c and confocal images A with E in ﬁ  gure 1d). VIP 
alone did not cause any increase in the F-actin contents 
or shape changes but caused a characteristic peripheral, 
membrane bound intracellular reorganization of F-actin in the 
spherical cells in a time-dependent manner (compare FACS 
results of 1 and 2 with 3 in Figure 1c and confocal images 
A and B with C in Figure 1d).
The crosstalk between different agonist stimulants 
of cell receptors may indicate a novel role for F-actin 
physical reorganization independent from shape changes 
and increase in its contents in mast cells migration. In 
this context it is possible that high and low afﬁ  nity recep-
tors of chemokines (FKN) on the surface of mast cells 
are differently linked to F-actin changes, ie, the optimal 
dose will cause a rapid increase in F-actin contents that 
is associated with the rapid intracellular reorganiza-
tion and shape changes through PKC epsilon and delta 
(El-Shazly et al 2006), while the suboptimal dose will 
only reorganize the F-actin homogeneously in a cluster-
like manner as shown in this study. On the other hand, 
chemotaxis primers of mast cells such as VIP may induce 
a calcium-independent change in the signal transduction 
towards tyrosine kinases and p38 MAPK as we reported 
elsewhere (El-Shazly et al 2006) that is linked to periph-
eral reorganization of the F-actin in the spherical cell in a 
membrane-bound manner without increasing the F-actin 
contents or causing shape changes as demonstrated in 
this study. This is further supported by previous reports 
linking the involvement of p38-MAPK with the physical 
reorganization of F-actin (Kutsuna et al 2004; Kobayashi 
et al 2006; Ju et al 2007; Kim et al 2008).
Taken collectively, the results presented herein may 
identify a signiﬁ  cant role for the unique pattern of the 
Ca2+-independent F-actin biophysical dynamics in human 
mast cells migratory response to crosstalk between 
mediators and cell type at the inﬂ  ammatory site. If so, 
then antagonists at the level of cell receptors may provide 
a therapeutic target for F-actin in treating mast cells in 
allergic inﬂ  ammation.
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